Lépjen offline állapotba az Player FM alkalmazással!
#78 – Jacob Trefethen on Global Health R&D
Manage episode 438776649 series 2607952
Jacob Trefethen oversees Open Philanthropy’s science and science policy programs. He was a Henry Fellow at Harvard University, and has a B.A. from the University of Cambridge.
You can find links and a transcript at www.hearthisidea.com/episodes/trefethen
In this episode we talked about open source the risks and benefits of open source AI models. We talk about:
- Life-saving health technologies which probably won't exist in 5 years (without a concerted effort) — like a widely available TB vaccine, and bugs which stop malaria spreading
- How R&D for neglected diseases works —
- How much does the world spend on it?
- How do drugs for neglected diseases go from design to distribution?
- No-brainer policy ideas for speeding up global health R&D
- Comparing health R&D to public health interventions (like bed nets)
- Comparing the social returns to frontier (‘Progress Studies’) to global health R&D
- Why is there no GiveWell-equivalent for global health R&D?
- Won't AI do all the R&D for us soon?
You can get in touch through our website or on Twitter. Consider leaving us an honest review wherever you're listening to this — it's the best free way to support the show. Thanks for listening!
86 epizódok
Manage episode 438776649 series 2607952
Jacob Trefethen oversees Open Philanthropy’s science and science policy programs. He was a Henry Fellow at Harvard University, and has a B.A. from the University of Cambridge.
You can find links and a transcript at www.hearthisidea.com/episodes/trefethen
In this episode we talked about open source the risks and benefits of open source AI models. We talk about:
- Life-saving health technologies which probably won't exist in 5 years (without a concerted effort) — like a widely available TB vaccine, and bugs which stop malaria spreading
- How R&D for neglected diseases works —
- How much does the world spend on it?
- How do drugs for neglected diseases go from design to distribution?
- No-brainer policy ideas for speeding up global health R&D
- Comparing health R&D to public health interventions (like bed nets)
- Comparing the social returns to frontier (‘Progress Studies’) to global health R&D
- Why is there no GiveWell-equivalent for global health R&D?
- Won't AI do all the R&D for us soon?
You can get in touch through our website or on Twitter. Consider leaving us an honest review wherever you're listening to this — it's the best free way to support the show. Thanks for listening!
86 epizódok
Minden epizód
×Üdvözlünk a Player FM-nél!
A Player FM lejátszó az internetet böngészi a kiváló minőségű podcastok után, hogy ön élvezhesse azokat. Ez a legjobb podcast-alkalmazás, Androidon, iPhone-on és a weben is működik. Jelentkezzen be az feliratkozások szinkronizálásához az eszközök között.